Harm Reduction Group AB

ST:NOHARM Sweden Tobacco
Market Cap
$619.94K
Skr6.95 Million SEK
Market Cap Rank
#38444 Global
#633 in Sweden
Share Price
Skr0.02
Change (1 day)
+0.00%
52-Week Range
Skr0.02 - Skr0.02
All Time High
Skr8.75
About

Harm Reduction Group AB (publ) provides legal nicotine products as a substitute for the harmful tobacco smoking. It also offers electronic cigarettes. The company offer its products under Norse, IVG, Aroma King, and other brands. It sells its products through physical stores, e-commerce, brands, and retail sales. The company was formerly known as Norse Impact AB (publ) and changed its name to Har… Read more

Harm Reduction Group AB (NOHARM) - Net Assets

Latest net assets as of September 2023: Skr53.03 Million SEK

Based on the latest financial reports, Harm Reduction Group AB (NOHARM) has net assets worth Skr53.03 Million SEK as of September 2023.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Skr160.69 Million) and total liabilities (Skr107.65 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets Skr53.03 Million
% of Total Assets 33.0%
Annual Growth Rate N/A
5-Year Change N/A
10-Year Change N/A
Growth Volatility N/A

Harm Reduction Group AB - Net Assets Trend (2020–2022)

This chart illustrates how Harm Reduction Group AB's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for Harm Reduction Group AB (2020–2022)

The table below shows the annual net assets of Harm Reduction Group AB from 2020 to 2022.

Year Net Assets Change
2022-09-30 Skr69.54 Million +126.14%
2021-09-30 Skr30.75 Million --
2020-09-30 Skr0.00 --

Equity Component Analysis

This analysis shows how different components contribute to Harm Reduction Group AB's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 0.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (September 2022)

Component Amount Percentage
Other Components Skr69.54 Million 100.00%
Total Equity Skr69.54 Million 100.00%

Harm Reduction Group AB Competitors by Market Cap

The table below lists competitors of Harm Reduction Group AB ranked by their market capitalization.

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Harm Reduction Group AB's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2021 to 2022, total equity changed from 30,750,000 to 69,539,000, a change of 38,789,000 (126.1%).
  • Net loss of 10,953,000 reduced equity.
  • New share issuances of 301,000 increased equity.
  • Other factors increased equity by 49,441,000.

Equity Change Factors (2021 to 2022)

Factor Impact Contribution
Net Income Skr-10.95 Million -15.75%
Share Issuances Skr301.00K +0.43%
Other Changes Skr49.44 Million +71.1%
Total Change Skr- 126.14%

Book Value vs Market Value Analysis

This analysis compares Harm Reduction Group AB's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 0.07x
  • The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2020-09-30 Skr0.00 Skr0.02 x
2021-09-30 Skr0.14 Skr0.02 x
2022-09-30 Skr0.24 Skr0.02 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Harm Reduction Group AB utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): -15.75%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: -6.17%
  • • Asset Turnover: 1.11x
  • • Equity Multiplier: 2.30x
  • Recent ROE (-15.75%) is above the historical average (-17.61%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2020 0.00% 0.00% 0.00x 0.00x Skr0.00
2021 -37.08% -14.33% 1.49x 1.74x Skr-14.48 Million
2022 -15.75% -6.17% 1.11x 2.30x Skr-17.91 Million

Industry Comparison

This section compares Harm Reduction Group AB's net assets metrics with peer companies in the Tobacco industry.

Industry Context

  • Industry: Tobacco
  • Average net assets among peers: $348,364,500
  • Average return on equity (ROE) among peers: -9.23%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Harm Reduction Group AB (NOHARM) Skr53.03 Million 0.00% 2.03x $307.16K
Haypp Grp Ab (HAYPP) $568.62 Million -4.86% 0.63x $182.81 Million
Nicoccino Holding AB (NICO) $128.11 Million -13.60% 0.02x $1.68 Million